title: A novel de novo exon 21 DNMT1 mutation causes cerebellar ataxia, deafness, and narcolepsy in a Brazilian patient.
abstract: OBJECTIVE
  Autosomal dominant cerebellar ataxia, deafness and narcolepsy (ADCA-DN) is caused by DNMT1 mutations. Diagnosing the syndrome can be difficult, as all clinical features may not be present at onset, HLA-DQB1*06:02 is often negative, and sporadic cases occur. We report on clinical and genetic findings in a 31-year-old woman with cerebellar ataxia, deafness, and narcolepsy, and discuss diagnostic challenges.
  
  
  METHODS
  Clinical and genetic investigation in a patient and family members.
  
  
  METHODS
  Ataxia clinic, São Paulo, Brazil.
  
  
  METHODS
  One patient and her family members.
  
  
  METHODS
  N/A.
  
  
  RESULTS
  Narcolepsy was supported by polysomnographic and multiple sleep latency testing. HLA-DQB1*06:02 was positive. CSF hypocretin-1 was 191 pg/mL (normal values > 200 pg/mL). Mild brain atrophy was observed on MRI, with cerebellar involvement. The patient, her asymptomatic mother, and 3 siblings gave blood samples for genetic analysis. DNMT1 exons 20 and 21 were sequenced. Haplotyping of polymorphic markers surrounding the mutation was performed. The proband had a novel DNMT1 mutation in exon 21, p.Cys596Arg, c.1786T > C. All 4 parental haplotypes could be characterized in asymptomatic siblings without the mutation, indicating that the mutation is de novo in the patient.
  
  
  CONCLUSIONS
  The Brazilian patient reported here further adds to the worldwide distribution of ADCA-DN. The mutation is novel, and illustrates a sporadic case with de novo mutation. We believe that many more cases with this syndrome are likely to be diagnosed in the near future, mandating knowledge of this condition and consideration of the diagnosis.
authors.affiliation: Department of Neurology, Ataxia Unit, Universidade Federal de São Paulo, São Paulo, Brazil. jlpedroso.neuro@gmail.com
authors.forename: José Luiz
authors.initials: JL
authors.lastname: Pedroso
authors.forename: Orlando Graziani
authors.initials: OG
authors.lastname: Povoas Barsottini
authors.forename: Ling
authors.initials: L
authors.lastname: Lin
authors.forename: Atle
authors.initials: A
authors.lastname: Melberg
authors.forename: Acary S B
authors.initials: AS
authors.lastname: Oliveira
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Mignot
mesh_terms: D000328:Adult; D001938:Brazil; D002524:Cerebellar Ataxia / Q000150:complications / Q000235:genetics*; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000235:genetics* / Q000502:physiology; D003638:Deafness / Q000150:complications / Q000235:genetics*; D005091:Exons / Q000235:genetics / Q000502:physiology; D005260:Female; D006801:Humans; D009290:Narcolepsy / Q000150:complications / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D017286:Polysomnography
chemical_list: D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases; C000619380:DNMT1 protein, human
keywords: Narcolepsy; cerebellar ataxia; de novo; deafness; novel DNMT1 mutation
references.citation: Nat Genet. 2011 Jun;43(6):595-600
references.pmid: 21532572
references.citation: Eur J Neurol. 1999 May;6(3):357-61
references.pmid: 10210919
references.citation: Hum Mol Genet. 2009 Aug 1;18(15):2875-88
references.pmid: 19433415
references.citation: Hum Mol Genet. 2012 May 15;21(10):2205-10
references.pmid: 22328086
references.citation: Ann Neurol. 2001 Jan;49(1):136-7
references.pmid: 11198287
references.citation: J Neurosci. 2011 Nov 16;31(46):16619-36
references.pmid: 22090490
references.citation: J Neurol Sci. 1995 Dec;134(1-2):119-29
references.pmid: 8747854
references.citation: Neurology. 1999 Dec 10;53(9):2190-2
references.pmid: 10599806
references.citation: Proc Natl Acad Sci U S A. 2011 May 31;108(22):8919-20
references.pmid: 21593412